These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 20395540)
1. VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans. Kellogg DL; Zhao JL; Wu Y; Johnson JM J Appl Physiol (1985); 2010 Jul; 109(1):95-100. PubMed ID: 20395540 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans. Kellogg DL; Zhao JL; Wu Y; Johnson JM J Appl Physiol (1985); 2012 Nov; 113(10):1512-8. PubMed ID: 22961270 [TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons. Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242 [TBL] [Abstract][Full Text] [Related]
4. Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans. Kellogg DL; Zhao JL; Wu Y J Appl Physiol (1985); 2009 Nov; 107(5):1438-44. PubMed ID: 19745188 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC Tasma Z; Rees TA; Guo S; Tan S; O'Carroll SJ; Faull RLM; Curtis MA; Christensen SL; Hay DL; Walker CS Br J Pharmacol; 2024 Aug; 181(15):2655-2675. PubMed ID: 38616050 [TBL] [Abstract][Full Text] [Related]
6. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. Kellogg DL; Zhao JL; Wu Y; Johnson JM J Appl Physiol (1985); 2011 May; 110(5):1406-13. PubMed ID: 21292837 [TBL] [Abstract][Full Text] [Related]
7. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855 [TBL] [Abstract][Full Text] [Related]
8. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222 [TBL] [Abstract][Full Text] [Related]
10. No direct role for A1/A2 adenosine receptor activation to reflex cutaneous vasodilatation during whole-body heat stress in humans. Fieger SM; Wong BJ Acta Physiol (Oxf); 2012 Jul; 205(3):403-10. PubMed ID: 22356216 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans. Bennett LA; Johnson JM; Stephens DP; Saad AR; Kellogg DL J Physiol; 2003 Oct; 552(Pt 1):223-32. PubMed ID: 12847205 [TBL] [Abstract][Full Text] [Related]